For media enquiries or more information about research at the Djavad Mowafaghian Centre for Brain Health, please contact Vanessa Hrvatin (Communications Coordinator) or Clement Woo (Communications Manager).

To keep in touch with the Centre and up-to-date on our research, follow us on Twitter or subscribe to Brain Matters, our monthly e-newsletter.

Dr. Jacquie Quandt in the lab at the Centre for Brain Health
Radical approach limits disease progression in experimental models of MS Mar 13, 2017

According to new research from Dr. Jacqueline Quandt, published recently in Brain, Behaviour and Immunity, a simple compound shows promise in altering immune responses without eliminating cells and in doing so protects the cells in the nervous system and prevents the underlying neurodegeneration in models of MS.

CIHR statement on CCSVI research findings Mar 9, 2017

Scientific Expert Working Group on Multiple Sclerosis/Chronic Cerebrospinal Venous Insufficiency reconvened to hear preliminary study results from Canadian Phase I/II Clinical Trial.

Controversial “liberation therapy” fails to treat multiple sclerosis: study Mar 8, 2017

The conclusions about so-called “liberation therapy,” which thousands of people with MS have undergone since 2009, represent the most definitive debunking of the claim that MS patients could achieve dramatic improvements from a one-time medical procedure.

Dr, Weihong Song
Member news: February 2017 Feb 24, 2017

Links to stories about and by members of the Djavad Mowafaghian Centre for Brain Health from January/February 2017.

Dr. Robin Hsiung, Ralph Fisher and Alzheimer Society of B.C. Professor in Alzheimer Disease
Dr. Robin Hsiung awarded Alzheimer and dementia research professorship Feb 23, 2017

The Alzheimer Society of B.C. and UBC celebrated a decade-long partnership in maintaining the Ralph Fisher and Alzheimer Society of B.C. Professorship in Alzheimer Disease Research earlier this week and welcomed Dr. Robin Hsiung, who was recently awarded the Professorship.

Epilepsy drug may be effective in treating migraine with aura
Epilepsy drug may be effective in treating migraine with aura Feb 21, 2017

New research from CURE-funded researcher Dr. Stuart Cain, in the laboratory of Dr. Terry Snutch shows that an approved epilepsy drug may be effective in treating migraine in mice.

Health Ministry to cover Parkinson’s medication Feb 15, 2017

In recognition of the challenges faced by British Columbians with Parkinson’s disease, the Ministry of Health will be working with the Pacific Parkinson’s Research Centre to identify and prioritize patients for coverage of the medication Duodopa.

Mutant mice resist addictive effects of cocaine in new study Feb 13, 2017

A team of researchers has genetically engineered a mouse that does not become addicted to cocaine, adding to the evidence that genetics and biochemistry play a significant role in drug addiction. The researchers, led by Dr. Shernaz Bamji, were able to reduce behaviours associated with cocaine addiction by regulating the effect of the drug on the synpases, preventing the drug from making lasting changes to the brain.

Dr. Cheryl Wellington is paving the way in Alzheimer’s research Jan 31, 2017

January is Alzheimer’s Awareness Month. Dr. Cheryl Wellington, a Professor in the Department of Pathology and Laboratory Medicine, has devoted her career to understanding the genetic and environmental risk factors that affect dementia. Her discovery of the role that apolipoprotein (ApoE) – a cholesterol carrier in the brain – plays in Alzheimer’s is internationally recognized and has offered us a better understanding of the disease.

Roots of Alzheimer’s disease can extend as far back as the womb Jan 27, 2017

The biochemical reactions that cause Alzheimer’s disease could be set in motion in the womb or just after birth if the fetus or newborn does not get enough Vitamin A, according to new research from the Djavad Mowafaghian Centre for Brain Health at the University of British Columbia.

Although it has long been known that Alzheimer’s disease unfolds in a person’s brain decades before symptoms appear, this is the first time the roots of the disease have been traced back to infancy or pre-natal development.